|
|
|||||||
Thrombosis |
From the Department of Pediatrics (TCN, KA); Thrombosis Research Section, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA (AL, LL, CB, HC, WSM, ALB, J-fD)
Correspondence: Jing-fei Dong, Thrombosis Research Section, Department of Medicine, BCM286, N1319, Baylor College of Medicine, One Baylor Plaza, Houston, TX, USA. E-mail: jfdong{at}bcm.tmc.edu
We studied the state of ultralarge von Willebrand factor (ULVWF) proteolysis in 21 pediatric patients with severe sepsis and found that the overall group of patients had moderately reduced ADAMTS-13 activity, but 31% had severe enzymatic deficiency. The severe deficiency correlated with greater adhesion activity of von Willebrand factor, severity of thrombocytopenia and plasma levels of interleukin-6. It also correlated clinically with severity of illness and organ dysfunction. These results suggest that ULVWF proteolysis is insufficient in septic patients and severely deficient in a subgroup of patients. The deficiency may contribute to the development of thrombocytopenia and ischemic organ failure associated with sepsis.
Key words: sepsis, ADAMTS-13, ULWF, thrombotic microangiopathy.
This article has been cited by other articles:
![]() |
C. V. Denis Pas de deux between VWF and ADAMTS13 Blood, April 1, 2008; 111(7): 3306 - 3307. [Full Text] [PDF] |
||||
![]() |
A. K. Chauhan, M. T. Walsh, G. Zhu, D. Ginsburg, D. D. Wagner, and D. G. Motto The combined roles of ADAMTS13 and VWF in murine models of TTP, endotoxemia, and thrombosis Blood, April 1, 2008; 111(7): 3452 - 3457. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Bockmeyer, R. A. Claus, U. Budde, K. Kentouche, R. Schneppenheim, W. Losche, K. Reinhart, and F. M. Brunkhorst Inflammation-associated ADAMTS13 deficiency promotes formation of ultra-large von Willebrand factor Haematologica, January 1, 2008; 93(1): 137 - 140. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | TABLE OF CONTENTS | ARCHIVE | SUBSCRIPTIONS |